CLEC10A and melanoma: Patients with serological response against HERV-K had a significantly decreased disease-specific overall survival.55 Additionally, HML-2 rec mRNA is expressed in melanoma cells but not in benign nevi or normal skin, indicating aberrant activation in melanoma.